We are live on ! Find out more
REVBU

Revelation Biosciences, Inc. Unit

Delisted

REVBU was delisted on the 11th of January, 2023.

4 hedge funds and large institutions have $10.9M invested in Revelation Biosciences, Inc. Unit in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% less capital invested

Capital invested by funds: $23.3M → $10.9M (-$12.5M)

64% less funds holding

Funds holding: 114 (-7)

78% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 9

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
-7
Holders Change %
-63.64%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
1
Closed
9
Calls
Puts
Net Calls
Net Calls Change

REVBU Hedge Fund Activity: Q1 2021 in Review

4 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences, Inc. Unit (REVBU) for Q1 2021, worth a combined $10.9M — down 53% from $23.3M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of REVBU and 2 opened new positions — a net loss of 7 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Cordasco Financial Network, opening a new position worth an estimated $55.6K. The largest seller was Polar Asset Management Partners, exiting entirely with an estimated $3.78M sold.

  • 4 institutional investors held Revelation Biosciences, Inc. Unit (REVBU) as of Q1 2021, down from 11 in Q4 2020.
  • Funds reported $10.9M of Revelation Biosciences, Inc. Unit stock for Q1 2021, down 53% quarter-over-quarter.
  • 2 funds opened new Revelation Biosciences, Inc. Unit positions in Q1 2021 and 9 closed out, a net change of -7 holders.
  • The largest Revelation Biosciences, Inc. Unit buyer in Q1 2021 was Cordasco Financial Network, an estimated $55.6K added.
  • The largest Revelation Biosciences, Inc. Unit seller in Q1 2021 was Polar Asset Management Partners, an estimated $3.78M sold.

Based on aggregated 13F filings for Q1 2021.